PortfoliosLab logo

Bicycle Therapeutics plc (BCYC)

Equity · Currency in USD · Last updated Mar 30, 2023

Share Price Chart


Loading data...

Performance

The chart shows the growth of $10,000 invested in Bicycle Therapeutics plc in Oct 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $19,333 for a total return of roughly 93.33%. All prices are adjusted for splits and dividends.


50.00%100.00%150.00%NovemberDecember2023FebruaryMarch
93.33%
42.72%
BCYC (Bicycle Therapeutics plc)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with BCYC

Bicycle Therapeutics plc

Return

Bicycle Therapeutics plc had a return of -21.62% year-to-date (YTD) and -45.54% in the last 12 months. Over the past 10 years, Bicycle Therapeutics plc had an annualized return of 18.70%, outperforming the S&P 500 benchmark which had an annualized return of 9.69%.


PeriodReturnBenchmark
1 month3.39%1.46%
Year-To-Date-21.62%4.90%
6 months1.98%10.43%
1 year-45.54%-11.97%
5 years (annualized)18.70%9.69%
10 years (annualized)18.70%9.69%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2023-6.69%-17.70%
2022-12.06%6.41%17.01%2.21%

Sharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Bicycle Therapeutics plc Sharpe ratio is -0.58. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-0.90-0.80-0.70-0.60-0.50-0.40-0.30-0.20NovemberDecember2023FebruaryMarch
-0.58
-0.51
BCYC (Bicycle Therapeutics plc)
Benchmark (^GSPC)

Dividend History


Bicycle Therapeutics plc doesn't pay dividends

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-70.00%-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%NovemberDecember2023FebruaryMarch
-62.05%
-16.03%
BCYC (Bicycle Therapeutics plc)
Benchmark (^GSPC)

Worst Drawdowns

The table below shows the maximum drawdowns of the Bicycle Therapeutics plc. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Bicycle Therapeutics plc is 78.82%, recorded on Jun 16, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-78.82%Nov 16, 2021147Jun 16, 2022
-53.96%Jun 20, 201949Aug 28, 2019117Feb 14, 2020166
-41.61%Mar 11, 20209Mar 23, 202046May 28, 202055
-25.95%Feb 8, 202118Mar 4, 202120Apr 1, 202138
-20.84%Jul 26, 202119Aug 19, 20217Aug 30, 202126
-18.83%Feb 27, 20202Feb 28, 20203Mar 4, 20205
-18.7%Jul 16, 202041Sep 11, 20203Sep 16, 202044
-16.36%Apr 9, 20212Apr 12, 202164Jul 13, 202166
-15.98%Jun 9, 202017Jul 1, 20208Jul 14, 202025
-15.96%Dec 1, 202022Dec 31, 20209Jan 14, 202131

Volatility Chart

Current Bicycle Therapeutics plc volatility is 64.85%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


10.00%20.00%30.00%40.00%50.00%60.00%70.00%80.00%NovemberDecember2023FebruaryMarch
64.85%
16.43%
BCYC (Bicycle Therapeutics plc)
Benchmark (^GSPC)